Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study

Race influences warfarin dose changes associated with genetic factors

(2015) N. A. Limdi et al.   BLOOD

Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

(2015) Hirotsugu Kenmotsu et al.   CANCER SCIENCE

Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child–Pugh Class, and Effects of Antibiotics

(2015) Puneeta Tandon et al.   Clinical Gastroenterology and Hepatology

Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia

(2015) Georgios N. Kalambokis et al.   LIVER INTERNATIONAL

Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis

(2014) J. S. Bajaj et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

(2014) J. S. Bajaj et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mining the Metabiome: Identifying Novel Natural Products from Microbial Communities

(2014) Aleksandr Milshteyn et al.   CHEMISTRY & BIOLOGY

Purinergic signaling via P2Y receptors up-mediates IL-6 production by liver macrophages/Kupffer cells

(2014) Makiko Ishimaru et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

Liver cirrhosis

(2014) Emmanuel A Tsochatzis et al.   LANCET

Alterations of the human gut microbiome in liver cirrhosis

(2014) Nan Qin et al.   NATURE

Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives

(2014) Giulia Malaguarnera   WORLD JOURNAL OF GASTROENTEROLOGY

Toxic epidermal necrolysis associated with rifaximin

(2013) A. S. Patel et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats

(2013) Dabo Xu et al.   GASTROENTEROLOGY

Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial

(2013) Philipp Zanger et al.   LANCET INFECTIOUS DISEASES

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

(2013) Jasmohan S. Bajaj et al.   PLoS One

The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization

(2013) M.A. Kane et al.   VACCINE

Probable rifaximin-induced neutropenia

(2012) L. M. Hynicka et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

(2012) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis

(2012) Jiannis Vlachogiannakos et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy

(2012) Cheng-Yuan Peng et al.   JOURNAL OF HEPATOLOGY

Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats

(2012) Gemma Òdena   WORLD JOURNAL OF GASTROENTEROLOGY

Rifaximin: New Therapeutic Indication and Future Directions

(2011) Anastasia Rivkin et al.   CLINICAL THERAPEUTICS

Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt

(2011) Jonel Trebicka et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Characterization of fecal microbial communities in patients with liver cirrhosis

(2011) Yanfei Chen et al.   HEPATOLOGY

Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice

(2011) Qiang Zhu et al.   JOURNAL OF HEPATOLOGY

The role of intestinal endotoxin in liver injury: A long and evolving history

(2010) James P. Nolan   HEPATOLOGY

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

(2010)   JOURNAL OF HEPATOLOGY

Rifaximin Treatment in Hepatic Encephalopathy

(2010) Nathan M. Bass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Probiotics and gut health: A special focus on liver diseases

(2010) Silvia Wilson Gratz   WORLD JOURNAL OF GASTROENTEROLOGY

Liver cirrhosis

(2008) Detlef Schuppan et al.   LANCET